MedPath

Aloe Vera in Irritable Bowel Syndrome

Not Applicable
Completed
Conditions
Irritable Bowel Syndrome
Interventions
Dietary Supplement: Placebo control
Dietary Supplement: Aloe vera effervescent tablet (AVH200)
Registration Number
NCT01400048
Lead Sponsor
Sahlgrenska University Hospital, Sweden
Brief Summary

The purpose of the present study is to study the effect of aloe vera in the treatment of IBS patients in a randomized, double-blind placebo controlled study.

Detailed Description

There is limited knowledge of the IBS pathophysiology, absence of biological markers and therefore few effective treatment options. IBS therefore contributes to difficulties in the management of the patients. Aloe vera has a long association with herbal medicine, from the Ebers Papyrus from 16th century BCE. It is alleged to be effective in treatment of wounds, to improve blood glucose levels in diabetics, and it may reduce symptoms and inflammation in patients with ulcerative colitis. Evidence of the effects of aloe vera in the treatment of IBS, is however limited and contradictory.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
173
Inclusion Criteria
  • IBS according to the Rome III criteria
  • Adults
Exclusion Criteria
  • other GI disorders
  • other medical conditions
  • were pregnancy or breast-feeding
  • food allergy or intolerance to other than lactose
  • ongoing intake of aloe vera products

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
PlaceboPlacebo control-
Aloe vera effervescent tablet (AVH200)Aloe vera effervescent tablet (AVH200)-
Primary Outcome Measures
NameTimeMethod
IBS symptoms4 weeks
Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Mag-tarmlab, Dept of Internal Medicine, Sahlgrenska University Hospital

🇸🇪

Gothenburg, Sweden

© Copyright 2025. All Rights Reserved by MedPath